Sort
34,240 grants matching “atherosclerosis”
Airway trees in the Anthropocene: Defining resilient airway trees and identifying the candidate mechanisms and etiologic factors that increase susceptibility to tobacco smoke and air pollution
$712,417Benjamin M. Smith · Columbia University Health Sciences · R01 · FY2022 · HL
Engineering an Atherosclerosis-Resistant Endothelium
$712,374Martin A. Schwartz · University Of Virginia · R01 · FY2010 · HL
The Role Of Nrf2 In Susceptibility To Hyperoxic Lung Injury
$712,350Steven R Kleeberger · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES
Premature aging disorders, metabolites, and atherosclerosis
$712,298Jun-Ichi Abe · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · HL
Using Fortilin Inhibitors to Block Atherosclerosis
$712,211Ken Fujise · University Of Texas Med Br Galveston · R01 · FY2017 · HL
Role of PXR in drug-elicited cardiovascular disease
$712,001Changcheng Zhou · University Of California Riverside · R01 · FY2025 · HL
Optimize Risk Assessment for Incident and Recurrent Atherosclerotic Cardiovascular Disease
$711,827Yiyi Zhang · Columbia University Health Sciences · R01 · FY2022 · HL
A Novel Endovascular Approach to Remove Atherosclerotic Plaque Lesions In Situ
$711,711Melina Rae Kibbe · Univ Of North Carolina Chapel Hill · R01 · FY2021 · HL
Non-Invasive Localization of Vulnerable Plaques
$711,522Cynthia H McCollough · Mayo Clinic Rochester · R01 · FY2008 · EB
PR-OUTLOOK: PR Young Adults' Stress, Contextual, Behavioral & Cardiometabolic Risk
$711,457Milagros C Rosal · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · HL
Functional Cardio-Metabolomics
$711,453Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · P20 · FY2012 · HL
Role of Mitochondrial Health in Acute and Chronic Kidney Disease in Older Adults
$711,421Michael G Shlipak · Northern California Institute/Res/Edu · R01 · FY2019 · AG
Long-Acting RNAi Therapy for Atherosclerosis and Insulin Resistance
$711,340Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2021 · HL
EPIDEMIOLOGY: OXIDATIVE STRESS AND EARLY ATHEROSCLEROSIS
$711,261University Of Minnesota Twin Cities · R01 · FY2003 · HL
Eye Determinants of Cognition (EyeDOC) Study
$711,223Alison G Abraham · Johns Hopkins University · R01 · FY2017 · AG
Epigenetic Mechanisms of PM-Mediated CVD Risk
$711,025Eric A. Whitsel · Univ Of North Carolina Chapel Hill · R01 · FY2012 · ES
Epidemiology: Oxidative Stress and Early Atherosclerosis
$711,001David R Jacobs · University Of Minnesota · R01 · FY2014 · HL
IGF::OT::IGF LEUKOCYTE TELOMERE DYNAMICS, CARDIOVASCULAR AGING AND SURVIVAL IN THE WOMEN'S HEALTH INITIATIVE LONG LIFE STUDY
$710,909N/a N/a · Fred Hutchinson Cancer Research Center · N01 · FY2014 · HL
Multi-Scale Biology of Atherosclerosis in the Cellular Adhesion Pathway
$710,837Suzette Janine Bielinski · Mayo Clinic Rochester · R01 · FY2012 · HL
Epidemiology of coronary artery disease among people with HIV in rural sub-Saharan Africa
$710,755Mark J Siedner · Massachusetts General Hospital · R01 · FY2019 · HL
Imaging the Vascular Consequences of Lipid Deposition
$710,553James Athur Hamilton · Boston University Medical Campus · P50 · FY2008 · HL
Genetic Architecture of Cardiac Structure and Function and Its Impact on Heart Failure
$710,546Bing Yu · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · HL
RNA binding proteins in atherosclerosis
$710,427Tamer Sallam · University Of California Los Angeles · R01 · FY2025 · HL
Intravascular NIRF-IVUS imaging of inflammation-guided arterial therapy
$710,328Farouc Amin Jaffer · Massachusetts General Hospital · R01 · FY2020 · HL
COLLOIDAL IRON-OXIDE NANOBEACONS FOR THERANOSTIC USE IN ATHEROSCLEROSIS
$710,188Gregory M Lanza · Washington University · R01 · FY2010 · HL